"Robust December" helps Danaher's Q4 beat analyst expectations
This article was originally published in Clinica
Executive Summary
Danaher is expecting to report organic revenue growth of over 3% in its fourth fiscal quarter, above the 1% increase anticipated by Jefferies analyst Jon Wood and consensus analyst estimates. The results, aided by what the analyst described as a "robust December showing", should push Q4 earnings-per-share above the company's previous guidance of $0.80-0.85.